RE:News!!! As mentioned the other day, take one country, Kenya, and based on their own projections they could be at least two to three years vaccinating the whole of the country. Multiply that by x no. of countries still struggling to get life in order and thus the need for tests appears staggering.
No one has a crystal ball but if the need remains over that timeframe and THRM can participate in a fraction of this, the revenue generated "could" also be staggering.
There are already complaints surfacing that the Abbott tests currently selling over the counter in Canada are too expensive at $.40. Should THRM be able to scale up production of AcuVid to the point that kits can sell for $10 (as Rob mentioned in his interview) they may eventually usurp tests already being considered and/or being sold across a number of jurisdictions.
The potential is overwhelming to consider.
GLTE!!!